Implantica
Swiss medtech company developing implantable medical devices for chronic conditions. Lead product RefluxStop is an FDA-approved and CE-marked implant for the treatment of gastroesophageal reflux disease (GERD).
Company Info
Upcoming Milestones & Key Dates
2026-08
Regulatory
FDA PMA approval for RefluxStop — U.S. market opening
2026-H2
Commercial
U.S. commercial launch activities
Clinical Development Pipeline
RefluxStop
Target: Lower esophageal sphincterRecent News
No recent news updates available for this company.